Delivery Order SPE2DB20D1109-SPE2DB24FP85X

Award Date 9/6/24
Potential Completion Date 9/9/24
Potential Value $5.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $20,364.67, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a total potential value of $999,999,999 and runs through November 2026. The contract provides for the delivery of phytonadione 1 mg/0.5 ml syrup in 0.5 ml doses to support...
This federal contract award, with the ID SPE2DB22D1106|SPE2DB25FEBA2, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,058.47 firm fixed-price delivery order is for the supply of Phytonadione 1 mg/0.5 ml syrup, 0.5 ml, with a period of performance through March 4, 2025. This contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This is a federal contract award by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Phytonadione 1 mg/0.5 ml syrup, with a ceiling value of $1,599.88. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $3,843.36, is for the delivery of phytonadione 1 mg/0.5 ml syrup (0.5 ml). This is a firm fixed-price delivery order contract with a completion date of January 16, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,162.64 Firm Fixed Price Delivery Order covers the supply of PHYTONADIONE 1 MG/0.5 ML SYR 0.5ML, a pharmaceutical product, with a performance period through January 2025. This award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,411.77 fixed-price delivery order is for the supply of 4,562,816,959 units of Phytonadione 5 mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the delivery of Phytonadione 1 mg/0.5 ml syrup. The contract has a ceiling value of $9,803.41 and a completion date of February 21, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp. is a major pharmaceutical distributor and healthcare solutions provider that supplies medical products to federal government agencies,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,816.84 Firm Fixed Price Delivery Order is for the supply of 4,560,394,455 phytonadione 5 mg tablets. This award is associated with a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,289.64, is for the delivery of 4,567,442,998 units of the medication phytonadione 1 mg/0.5 ml syringe. The contract has a firm fixed price and an ultimate completion date of March 4, 2025. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a federal contract award issued by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,568,210,645 units of the drug phytonadione in 0.5 mL doses, with a ceiling value of $8,508.35. The contract is a Firm Fixed Price Delivery Order with a completion date of June 9, 2025. The contract is not set-aside and is open to full and open competition. AmerisourceBergen Drug Corp is the prime...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB24FP85X
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,426.64 firm fixed-price delivery order is for the supply of 4565711529 - Phytonadione 1 mg/0.5 ml syrup, 0.5 ml. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. In addition to the DLA contract, AmerisourceBergen also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 2/27/25, 11:23 AM